Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial

Conditions

Pediatric OCD Mental and Behavioural Disorders Obsessive-compulsive disorder

Bernhard Weidle, Lucía Babiano-Espinosa, Norbert Skokauskas, Lidewij H. Wolters, Marit Henriksen et al. (10 authors)

Child Psychiatry & Human Development2024-08-173 citations

Feasibility, Acceptability, and Effectiveness of Enhanced Cognitive Behavioral Therapy (eCBT) for Children and Adolescents With Obsessive-Compulsive Disorder: Protocol for an Open Trial and Therapeutic Intervention

Lidewij H. Wolters, Bernhard Weidle, Lucía Babiano-Espinosa, Norbert Skokauskas

JMIR Research Protocols2020-11-1714 citations

10.2196/24057

Interventions

Current interventions as of 11/06/2020: Until 16 March 2020, all participants received enhanced cognitive behavioral therapy (eCBT) for pediatric OCD. eCBT consists of the usual, evide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 7–17 years (inclusive) 2. A primary DSM 5 diagnosis of obsessive-compulsive disorder 3. CY-BOCS = 16

Exclusion criteria

Exclusion criteria: 1. A psychiatric comorbidity that has a higher treatment priority than OCD, and makes participation clinically inappropriate (for example, primary anorexia nervosa, depression with suicidality that requires acute treatment, and psychosis) 2. (Estimated) IQ below 70 3. Insufficient understanding of the Norwegian or English language

Design outcomes

Primary

Measure	Time frame
1. Acceptability assessed using Client Satisfaction Questionnaire (CSQ-8), child and parent version post-treatment 2. Feasibility: preterm treatment drop-out measured post-treatment 3. Effectiveness assessed using the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) administered by a blind rater (blinded for treatment phase) pre- and post-treatment, and at 3 and 6 months follow-up	—

Secondary

Measure	Time frame
Acceptability assessed using: 1. Treatment evaluation questionnaire (child and parent version) composed of the User Experience Questionnaire and (self-developed) treatment-specific questions, measured post-treatment 2. Barriers to Treatment Participation Scale (BTPS). For the aim of the present study the researchers shortened the questionnaire and added a child version. Measured post-treatment. Effectiveness assessed using: 1. K-SADS-Pl at pre- and post-treatment 2. Child Obsessive-Compulsive Impact Scale (COIS-R): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 3. Family Accommodation Scale for OCD – Self-Rated Version (FAS-SR): parents at pre- and post-treatment, 3 and 6 months follow-up 4. Strengths and Difficulties Questionnaire (SDQ): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 5. Child Behavior Checklist (CBCL): parents at pre- and post-treatment, 6 months follow-up 6. Youth Self-Report Questionnaire (YSR): children 11 years and older at pre- and post-treatment, 6 months follow-up 7. Screen for Child Anxiety Related Emotional Disorders (SCARED): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 8. Mood and Feelings Questionnaire (MFQ): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 9. KINDL: child and parent version at pre- and post-treatment, 3 and 6 months follow-up 10. Children’s Global Assessment Scale (CGAS) at pre- and post-treatment, 3 and 6 months follow-up 11. Clinical Global Impressions-Severity (CGI-S) at pre- and post-treatment, 3 and 6 months follow-up 12. Clinical Global Impressions Improvement (CGI–I) at post-treatment, 3 and 6 months follow-up 13. The Trimbos/iMTA Questio	—

Measure

Time frame

Acceptability assessed using: 1. Treatment evaluation questionnaire (child and parent version) composed of the User Experience Questionnaire and (self-developed) treatment-specific questions, measured post-treatment 2. Barriers to Treatment Participation Scale (BTPS). For the aim of the present study the researchers shortened the questionnaire and added a child version. Measured post-treatment. Effectiveness assessed using: 1. K-SADS-Pl at pre- and post-treatment 2. Child Obsessive-Compulsive Impact Scale (COIS-R): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 3. Family Accommodation Scale for OCD – Self-Rated Version (FAS-SR): parents at pre- and post-treatment, 3 and 6 months follow-up 4. Strengths and Difficulties Questionnaire (SDQ): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 5. Child Behavior Checklist (CBCL): parents at pre- and post-treatment, 6 months follow-up 6. Youth Self-Report Questionnaire (YSR): children 11 years and older at pre- and post-treatment, 6 months follow-up 7. Screen for Child Anxiety Related Emotional Disorders (SCARED): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 8. Mood and Feelings Questionnaire (MFQ): child and parent version at pre- and post-treatment, 3 and 6 months follow-up 9. KINDL: child and parent version at pre- and post-treatment, 3 and 6 months follow-up 10. Children’s Global Assessment Scale (CGAS) at pre- and post-treatment, 3 and 6 months follow-up 11. Clinical Global Impressions-Severity (CGI-S) at pre- and post-treatment, 3 and 6 months follow-up 12. Clinical Global Impressions Improvement (CGI–I) at post-treatment, 3 and 6 months follow-up 13. The Trimbos/iMTA Questio

—

Countries

Norway

Outcome results

None listed